ASCO is perhaps one of the most anticipated events in the scientific calendar and every year it draws more than 30,000 oncology professionals from around the world to discuss key advances in cancer research. This year it was held in Chicago, USA with a scientific program expanding over five days, and through the Sydney Vital Travel Award, Dr Aaron Tan was able to attend to present his research findings in a poster discussion session.
This year the theme focused on “Delivering discoveries: expanding the reach of precision medicine” focuses on making precision medicine a reality by driving progress and expanding its reach so that every patient can have the opportunity to benefit,” Dr. Bruce Johnson, ASCO President.
In the poster discussion session, the invited discussant, Dr Harriet Kluger from Yale University, emphasised the importance of research findings in providing evidence to support the use of PET scans in patients treated with anti-PD-1 based therapy with metastatic melanoma.
The opportunity gave Dr Tan the opportunity to attend an international conference and to learn about the latest developments in oncology. He notes that the lung cancer sessions in particular were full with trials illustrating the importance and benefits of immunotherapy. Attending ASCO has allowed Aaron to meet and engage with international colleagues which could provide collaboration opportunities in the future. We would like to wish him the best of luck in his career and will continue to support him.
Keep up-to-date with our scholarships, funding and awards and check out our grant schemes here.
Dr Aaron Tan